Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Jun;34(6):1506–1511. doi: 10.1128/jcm.34.6.1506-1511.1996

Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii.

M Gorgievski-Hrisoho 1, D Germann 1, L Matter 1
PMCID: PMC229051  PMID: 8735107

Abstract

We evaluated immunoglobulin M (IgM) and IgA assays that could improve the predictive value for recently acquired toxoplasma infection for patients with positive screening test results. Follow-up sera were collected from 82 patients whose initial serum specimen had a reactive anti-Toxoplasma gondii IgM result. According to the evolution of the immune response, patients were divided retrospectively into two groups: one in which a recent infection was unlikely and the other one with an evolving immune response suggestive of recent toxoplasma infection. All IgM and one of three IgA assays used in the study are suitable for screening pregnant patients, with a negative predictive value of 100%. The predictive value of positive results is much lower because of the low prevalence of acute toxoplasmosis in pregnant women and the long persistence of IgM after acute infection. In the present study, all except one IgM enzyme immunoassay remained positive well beyond 6 months after the initial sample was tested. The IgM immunofluorescence test had the shortest persistence of positivity in most cases. IgA tests were either too insensitive or remained reactive too long to be useful for screening pregnant patients. Interpreting enzyme immunoassays with modified cutoff values and the combination of two tests could improve the predictive value of positive results to about 80% in terms of recent infection.

Full Text

The Full Text of this article is available as a PDF (292.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E. Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol Infect. 1991 Dec;107(3):527–535. doi: 10.1017/s0950268800049220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aspöck H., Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl. 1992;84:32–37. [PubMed] [Google Scholar]
  3. Berrebi A., Kobuch W. E., Bessieres M. H., Bloom M. C., Rolland M., Sarramon M. F., Roques C., Fournié A. Termination of pregnancy for maternal toxoplasmosis. Lancet. 1994 Jul 2;344(8914):36–39. doi: 10.1016/s0140-6736(94)91054-5. [DOI] [PubMed] [Google Scholar]
  4. Brooks R. G., McCabe R. E., Remington J. S. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis. 1987 Sep-Oct;9(5):1055–1062. doi: 10.1093/clinids/9.5.1055. [DOI] [PubMed] [Google Scholar]
  5. COUVREUR J., DESMONTS G. Congenital and maternal toxoplasmosis. A review of 300 congenital cases. Dev Med Child Neurol. 1962 Oct;4:519–530. [PubMed] [Google Scholar]
  6. Couvreur J., Thulliez P., Daffos F., Aufrant C., Bompard Y., Gesquière A., Desmonts G. Foetopathie toxoplasmique. Traitement in utero par l'association pyriméthamine-sulfamides. Arch Fr Pediatr. 1991 Jun-Jul;48(6):397–403. [PubMed] [Google Scholar]
  7. Decoster A., Darcy F., Caron A., Capron A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet. 1988 Nov 12;2(8620):1104–1107. doi: 10.1016/s0140-6736(88)90523-5. [DOI] [PubMed] [Google Scholar]
  8. Desmonts G., Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974 May 16;290(20):1110–1116. doi: 10.1056/NEJM197405162902003. [DOI] [PubMed] [Google Scholar]
  9. Forestier F., Daffos F., Hohlfeld P., Lynch L. Les foetopathies infectieuses. Prévention, diagnostic prénatal, attitude pratique. Presse Med. 1991 Sep 28;20(30):1448–1454. [PubMed] [Google Scholar]
  10. Guerina N. G., Hsu H. W., Meissner H. C., Maguire J. H., Lynfield R., Stechenberg B., Abroms I., Pasternack M. S., Hoff R., Eaton R. B. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994 Jun 30;330(26):1858–1863. doi: 10.1056/NEJM199406303302604. [DOI] [PubMed] [Google Scholar]
  11. Hall S. M. Congenital toxoplasmosis. BMJ. 1992 Aug 1;305(6848):291–297. doi: 10.1136/bmj.305.6848.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hengst P. Screening for toxoplasmosis in pregnant women: presentation of a screening programme in the former "East"-Germany, and the present status in Germany. Scand J Infect Dis Suppl. 1992;84:38–42. [PubMed] [Google Scholar]
  13. Henri T., Jacques S., Rene L. Twenty-two years screening for toxoplasmosis in pregnancy: Liege-Belgium. Scand J Infect Dis Suppl. 1992;84:84–85. [PubMed] [Google Scholar]
  14. Hohlfeld P., Daffos F., Costa J. M., Thulliez P., Forestier F., Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994 Sep 15;331(11):695–699. doi: 10.1056/NEJM199409153311102. [DOI] [PubMed] [Google Scholar]
  15. Hohlfeld P., Daffos F., Thulliez P., Aufrant C., Couvreur J., MacAleese J., Descombey D., Forestier F. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989 Nov;115(5 Pt 1):765–769. doi: 10.1016/s0022-3476(89)80660-2. [DOI] [PubMed] [Google Scholar]
  16. Jacquier P., Hohlfeld P., Vorkauf H., Zuber P. Epidémiologie de la toxoplasmose en Suisse: étude nationale de séroprévalence menée chez les femmes enceintes en 1990-1991. Schweiz Med Wochenschr Suppl. 1995;65:29S–38S. [PubMed] [Google Scholar]
  17. Joynson D. H. Epidemiology of toxoplasmosis in the U.K. Scand J Infect Dis Suppl. 1992;84:65–69. [PubMed] [Google Scholar]
  18. Lappalainen M., Koskela P., Koskiniemi M., Ammälä P., Hiilesmaa V., Teramo K., Raivio K. O., Remington J. S., Hedman K. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis. 1993 Mar;167(3):691–697. doi: 10.1093/infdis/167.3.691. [DOI] [PubMed] [Google Scholar]
  19. Montoya J. G., Remington J. S. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis. 1995 Apr;20(4):781–789. doi: 10.1093/clinids/20.4.781. [DOI] [PubMed] [Google Scholar]
  20. Peckham C. S., Logan S. Screening for toxoplasmosis during pregnancy. Arch Dis Child. 1993 Jan;68(1 Spec No):3–5. doi: 10.1136/adc.68.1_spec_no.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pinon J. M., Thoannes H., Pouletty P. H., Poirriez J., Damiens J., Pelletier P. Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using a non-enzymatic IgA-capture assay. Diagn Immunol. 1986;4(5):223–227. [PubMed] [Google Scholar]
  22. Pons J. C., Sigrand C., Grangeot-Keros L., Frydman R., Thulliez P. Toxoplasmose congénitale: transmission au foetus d'une infection maternelle antéconceptionnelle. Presse Med. 1995 Jan 21;24(3):179–182. [PubMed] [Google Scholar]
  23. Raeber P. A., Biedermann K., Just M., Zuber P. Die Prävention der kongenitalen Toxoplasmose in Europa. Schweiz Med Wochenschr Suppl. 1995;65:96S–102S. [PubMed] [Google Scholar]
  24. Remington J. S., Miller M. J., Brownlee I. IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med. 1968 May;71(5):855–866. [PubMed] [Google Scholar]
  25. Roizen N., Swisher C. N., Stein M. A., Hopkins J., Boyer K. M., Holfels E., Mets M. B., Stein L., Patel D., Meier P. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics. 1995 Jan;95(1):11–20. [PubMed] [Google Scholar]
  26. Stepick-Biek P., Thulliez P., Araujo F. G., Remington J. S. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis. 1990 Jul;162(1):270–273. doi: 10.1093/infdis/162.1.270. [DOI] [PubMed] [Google Scholar]
  27. Stray-Pedersen B., Jenum P. Current status of toxoplasmosis in pregnancy in Norway. Scand J Infect Dis Suppl. 1992;84:80–83. [PubMed] [Google Scholar]
  28. Thalhammer O. Prevention of congenital toxoplasmosis. Neuropadiatrie. 1973 Jul;4(3):233–237. doi: 10.1055/s-0028-1091742. [DOI] [PubMed] [Google Scholar]
  29. Thulliez P., Daffos F., Forestier F. Diagnosis of Toxoplasma infection in the pregnant woman and the unborn child: current problems. Scand J Infect Dis Suppl. 1992;84:18–22. [PubMed] [Google Scholar]
  30. Wong S. Y., Remington J. S. Toxoplasmosis in pregnancy. Clin Infect Dis. 1994 Jun;18(6):853–862. doi: 10.1093/clinids/18.6.853. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES